Jessica P. Hwang, M.D., MPH
Department of General Internal Medicine, Division of Internal Medicine
In the News
Present Title & Affiliation
Primary Appointment
Professor, Tenured, Department of General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1996 | McGovern Medical School at UTHealth Houston, Houston, TX, USA, MD, MD |
| 1996 | Emory University, Rollins School of Public Health, Atlanta, GA, USA, MPH, International Health and Epidemiology |
| 1991 | The University of Texas, Austin, TX, USA, BA, French Studies Plan 1 Honors |
Postgraduate Training
| 2024-2024 | Mindfulness-Based Stress Reduction Training (MBSR), University of Massachusetts Memorial Medical Center, Worcester, MA |
| 2024-2024 | Wellcoaches Health Coaching Training, Wellcoaches Corporation, Lancaster, OH |
| 2023-2024 | Faculty Development Leave, MD Anderson Cancer Center, Houston, TX |
| 2023-2023 | Certification in Lifestyle Medicine, Physician Pathway, American Board of Lifestyle Medicine, Riverside, CA |
| 2023-2023 | Culinary Medicine, University of Texas School of Public Health, Houston, TX |
| 2023-2023 | Basic Motivational Interviewing Training, Jope Consulting Services, Houston, TX |
| 2021-2024 | Certification in Implementation Science, University of California at San Francisco, San Francisco, CA |
| 2010-2010 | Clinical Safety and Effectiveness (CS&E) Program, "Patient Scheduling and Appointment Cycle Time in the Ambulatory Treatment Center", The University of Texas MD Anderson Cancer Center, Houston, TX |
| 1996-2000 | Internal Medicine and Pediatrics Residency, The University of Texas Medical School, Houston, TX |
| 1995-1995 | William and Flora Hewlett Internship, Carter Presidential Center, Atlanta, GA |
Board Certifications
| 2024 | American Board of Lifestyle Medicine |
| 2013 | American Board of Internal Medicine Recertification |
| 2002 | American Board of Internal Medicine |
Experience & Service
Academic Appointments
Associate Professor, Tenured, Department of General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2018
Assistant Professor, Tenure track, Department of General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005 - 2012
Assistant Professor, Non-tenure track, Department of General Internal Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2001 - 2005
Administrative Appointments/Responsibilities
Deputy Department Chair for Research, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present
Fellowship Program Director for General Internal Medicine, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Other Appointments/Responsibilities
Steering Committee Member, Texas Department of State Health Services, Texas Statewide Hepatitis Elimination Plan, Houston, TX, 2023 - 2023
Member, The Texas Collaborative Center for Hepatocellular Cancer (TeCH) Steering Committee, Houston, TX, 2019 - Present
Member, ASCO Cancer Prevention Committee (Education Work Group), Alexandria, VA, 2018 - 2019
Co-Chair, ASCO Provisional Clinical Opinion Committee on Hepatitis B Testing, Alexandria, VA, 2013 - 2021
Member, Community Clinical Oncology Program Research Base Steering Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - Present
Honors & Awards
| 2024 | Fellow, American Association for the Study of Liver Diseases |
| 2023 | Quality of Improvement and Patient Safety Award, DoIM Faculty Excellence in Quality, The University of Texas MD Anderson Cancer Center |
| 2021 | President’s Recognition of Faculty Excellence Award, Research Excellence, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center |
| 2020 | President's Recognition of Faculty Excellence in Prevention Outreach, The University of Texas MD Anderson Cancer Center |
| 2017 | Winner, James S. and Suzanne Cyrus Scholar Award for Clinical Research, "Models to Predict Hepatitis B Virus Infection Among Patients with Cancer Undergoing Systemic Anti-Cancer Therapy: Prospective Cohort Study, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center |
| 2016 | "Predictors of Positive Test Results in Patients with Cancer Undergoing Hepatitis B Screening Before Chemotherapy," Finalist for the Faculty Excellence in Research Poster Award, The University of Texas MD Anderson Cancer Center, Cancer Survivorship Research Symposium |
| 2016 | Nominee, Division of Internal Medicine Faculty Excellence in Research Award, The University of Texas MD Anderson Cancer Center |
| 2011 | Winner, James S. and Suzanne Cyrus Scholar Award for Clinical Research, "Reactivation of Hepatitis B Infection Among Patients with Cancer." Division of Internal Medicine, The University of Texas MD Anderson Cancer Center |
| 2011 | Fellow, American College of Physicians |
| 2011 | "Reactivation of Hepatitis B Infection Among Patients with Cancer," selected as one of the Best AASLD Abstracts at the British Association for the Study of the Liver Annual Meeting, British Association for the Study of the Liver |
| 2010 | "Reactivation of Hepatitis B Infection Among Patients with Cancer," selected as one of the Best of ASCO Abstracts at Multinational Association of Supportive Care in Cancer Annual Meeting, Multinational Association of Supportive Care in Cancer |
| 2008 | National Institutes of Health Loan Repayment Program in Health Disparities, Loan Repayment Program, NIH |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Torres HA, Mustafayev K, Juneau R, Hwang JP , Wang LS, Angelidakis G, Hawk E, Granwehr BP, Yepez Guevara E, Ying AK. Implementation of Universal Hepatitis C Virus Screening in a Tertiary Care Cancer Center. JNCCN, 2024. PMID: 38729204.
- Heredia NI, John JC, Singh S, Hwang JP, Strong LS, Balakrishnan M, McNeill LH. Understanding primary care physician perspectives on the diagnosis and management of non-alcoholic fatty liver disease: A qualitative study. INQUIRY, 2024. PMID: 38529894.
- Vaidya R, Unger JM, Loomba R, Hwang JP, Chugh R, Tincopa MA, Arnold KB, Hershman DL, Ramsey DL. Universal Viral Screening of Newly Diagnosed Cancer Patients in the United States: A Cost Efficiency Evaluation. Cancer Research Communications, 2023.
- Unger JM, Till C, Hwang JP, Arnold KB, Leblanc M, Hershman DL, Ramsey SD. Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patients. J Natl Cancer Inst 115(6):703-711, 2023. PMID: 36946291.
- Chiu CY, Patel K, Thomas SK, Khawaja F, Dailey Garnes NJM, Lee HC, Ohanian M, Jiang Y, Wang LS, Hwang JP, Torres HA. Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies. Hepatol Int 17(2):509-511, 2023. e-Pub 2022. PMID: 36477692.
- Klingen JT, Mustafayev K, Yibirin M, Hwang JP, Torres HA. False-Reactive Hepatitis B Surface Antigen Test Results in Cancer Patients. Eur J Clin Microbiol Infect Dis 42(3):383-385, 2023. e-Pub 2023. PMID: 36683093.
- Hwang JP, Arnold KB, Unger JM, Chugh R, Tincopa MA, Loomba R, Hershman D, Ramsey SD. Antiviral Therapy Use and Related Outcomes in Patients with Cancer and Viral Infections: Results from SWOG S1204. Support Care Cancer 31(1):93, 2022. e-Pub 2022. PMID: 36585488.
- Razouki ZA, Zhang X, Hwang JP, Heredia NI. Clinical Factors Associated with Non-Obese Nonalcoholic Fatty Liver Disease Detected among US Adults in the NHANES 2017-2018. J Clin Med 11(15), 2022. e-Pub 2022. PMID: 35893351.
- Hwang JP, Artz AS, Shah P, Symington B, Feld JJ, Hammond SP, Ludwig E, Pai A, Ramsey SD, Schlam I, Suga JM, Wang SH, Somerfield MR. Practical Implementation of Universal Hepatitis B Virus Screening for Patients with Cancer. JCO Oncol Pract:OP2200074. e-Pub 2022. PMID: 35700421.
- Harrison AC, Kanwal F, Asrani SK, Thrift AP, Amos CI, Jibaja-Weiss ML, Montealegre JR, Hwang JP, Singal AG, El-Serag HB. The Texas collaborative center for hepatocellular cancer: Reducing liver cancer mortality in Texas through coordination, collaboration and advocacy. Front Oncol 12:953933, 2022. e-Pub 2022. PMID: 36059708.
- Hwang JP, Huang D, Vierling JM, Suarez-Almazor ME, Shih Y, Chavez-MacGregor M, Duan Z, Giordano S, Hershman DL, Fisch MJ, Cantor SB.. Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients with Hematologic of Solid Malignancies Anticipating Immunosuppressive Cancer Therapy. JCO Clinical Cancer Informatics 3:1-12, 2019. PMID: 30892921.
- Ramsey SD, Unger JM, Baker LH, Little RF, Loomba R, Hwang JP, Chugh R, Konerman MA, Arnold K, Menter AR, Thomas E, Michels RM, Jorgensen CW, Burton GV, Bhadkamkar NA, Hershman DL.. The Prevalence of Hepatitis B, Hepatitis C, and HIV Infection among Newly Diagnosed Cancer Patients Treated in Academic and Community Oncology Practices: SWOG S1204. JAMA Oncology, 2019. PMID: 30653226.
- Golabi P, Paik J, Hwang JP, Wang S, Lee HM, Younossi ZM.. Prevalence and Outcomes of Non-Alcoholic Fatty Liver Disease (NAFLD) Among Asian American Adults in the United States. Liver Int, 2018. PMID: 30597715.
- Pauly MP, Tucker LY, Szpakowski JL, Ready JB, Baer D, Hwang JP, Lok AS.. Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-Term Treatment with Tumor Necrosis Factor Antagonists. Clin Gastroenterol Hepatol 16(12):1964-1973.e1, 2018. PMID: 29702293.
- Hwang JP, and Torres H. Hepatitis B Virus and Hepatitis C Virus Infection in Immunocompromised Patients. Curr Opin Infect Dis 31(6):535-541, 2018. PMID: 30299355.
- Hwang JP, Lok AS, Fisch MJ, Cantor SB, Barbo A, Lin HY, Foreman JT, Vierling JM, Torres HA, Granwehr BP, Miller E, Eng C, Simon GR, Ahmed S, Ferrajoli A, Romaguera J, Suarez-Almazor ME. Models to Predict Hepatitis B Virus Infection Among patients with Cancer Undergoing Systemic Anti-Cancer Therapy: A Prospective Cohort Study (selected for accompanying editorial). J Clin Oncol JCO2017756387, 2018. e-Pub 2018. PMID: 29447061.
- Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS, Bzowej NH, Wong JB. Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance. Hepatology 67(4):1560-1599, 2018. e-Pub 2018. PMID: 29405329.
- Angelidakis G, Hwang JP, Dandachi D, Economides MP, Hosry J, Granwehr BP, Torres HA. Universal Screening for Hepatitis C: A Needed Approach in Patients with Hematologic Malignancies. J Viral Hepat. e-Pub 2018. PMID: 29660201.
- Hwang JP, Ahmed S, Ariza-Heredia EJ, Duan Z, Zhao H, Schmeler KM, Ramondetta L, Parker SL, Suarez-Almazor ME, Ferrajoli A, Shih YT, Giordano SH, Chiao EY. Low Rate of Women with Hematologic Malignancies after Stem Cell Transplant. Biol Blood Marrow Transplant. e-Pub 2018. PMID: 29378304.
- Mak LY, Cruz-Ramón V, Chinchilla-López P, Torres HA, LoConte NK, Rice JP, Foxhall LE, Sturgis EM, Merrill JK, Bailey HH, Méndez-Sánchez N, Yuen MF, Hwang JP. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma. Am Soc Clin Oncol Educ Book, 2018. PMID: 30231359.
- Hwang JP, Suarez-Almazor ME, Cantor SB, Barbo A, Lin HY, Ahmed S, Chavez-MacGregor M, Donato-Santana C, Eng C, Ferrajoli A, Fisch MJ, McLaughlin P, Simon GR, Rondon G, Shpall EJ, Lok AS. Impact of the Timing of Hepatitis B Virus Identification and Anti-Hepatitis B Virus Therapy Initiation on the Risk of Adverse Liver Outcomes for Patients Receiving Cancer Therapy. Cancer 123(17):3367-3376, 2017. e-Pub 2017. PMID: 28518219.
- Unger JM, Hershman DL, Arnold KB, Loomba R, Chugh R, Hwang JP, O'Rourke MA, Bhadkamkar NA, Wang LX, Siegel AB, Cooley TP, Berenberg JL, Bridges BB, Ramsey SD. Stepwise Development of a Cancer Care Delivery Research Study to Evaluate the Prevalence of Virus Infections in Cancer Patients. Future Oncol 12(10):1219-31, 2016. e-Pub 2016. PMID: 26952901.
- Terrault NA, Bzowej NH, Chang KM, Hwang JP, Jonas MM, Murad MH. AASLD Guidelines for Treatment of Chronic Hepatitis B. Hepatology 63(1):261-283, 2016. e-Pub 2015. PMID: 26566064.
- Hwang JP, Somerfield MR, Alston-Johnson DE, Cryer DR, Feld JJ, Kramer BS, Sabichi AL, Wong SL, Artz AS. Reply to J. Cabezas et al. J Clin Oncol 34(3):290-1, 2016. e-Pub 2015. PMID: 26644541.
- Kyvernitakis A, Taremi M, Blechacz B, Hwang J, Jiang Y, Mahale P, Torres HA. Impact of Hepatitis E Virus Seropositivity on Chronic Liver Disease in Cancer Patients with hepatitis C virus infection. Hepatol Res 45(11):1146-51, 2015. e-Pub 2015. PMID: 25488194.
- Hwang JP, Granwehr BP, Torres HA, Suarez-Almazor ME, Giordano TP, Barbo AG, Lin HY, Fisch MJ, Chiao EY. HIV Testing in Patients with Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer Center. J Oncol Pract 11(5):384-90, 2015. e-Pub 2015. PMID: 26243649.
- Hwang JP, Somerfield MR, Alston-Johnson DE, Cryer DR, Feld JJ, Kramer BS, Sabichi AL, Wong SL, Artz AS. Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update (selected for translation and publication in the Spanish edition). J Clin Oncol 33(19):2212-20, 2015. e-Pub 2015. PMID: 25964247.
- Hwang JP, Artz AS, Somerfield MR. Hepatitis B Virus Screening for Patients with Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update. J Oncol Pract 10.1200/jop.2015.004846, 2015. PMID: 25964247.
- Hwang JP, Barbo A, Perrillo R.. Hepatitis B Reactivation During Cancer Chemotherapy: an International Survey of the Membership of the American Association for the Study of Liver Diseases. J Viral Hepat, 2014. PMID: 25220947.
- Hwang JP, Suarez-Almazor ME, Torres HA, Palla SL, Huang DS, Fisch MJ, Lok ASF, Huang D, Fisch M, Lok A.. Hepatitis C Screening in Cancer Patients Receiving Chemotherapy. J Oncol Pract 10(3):e167-74, 2014. e-Pub 2014. PMID: 24594679.
- Hwang JP, Lok, AS.. Management of Patients with Hepatitis B Who Require Immunosuppressive Therapy. Nat Rev Gastroenterol Hepatol(4):209-19, 2014. e-Pub 2013. PMID: 24247262.
- Hwang JP, Fisch MJ, Lok AS, Zhang H, Vierling JM, Suarez-Almazor ME.. Trends in Hepatitis B Virus Screening at the Onset of Chemotherapy in a Large US Cancer Center. BMC Cancer, 2013. PMID: 24209764.
- Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Hwang JP, Davila M, Torres HA. Acute Exacerbation and Reactivation of Chronic Hepatitis C Virus Infection in Cancer Patients. J Hepatol 57(6):1177-85, 2012. e-Pub 2012. PMID: 22871500.
Editorials
- Hwang JP, Lok AS. USPSTF 2020 Hepatitis B Screening Recommendation: Evidence to Broaden Screening and Strengthen Linkage to Care. Invited editorial commenting on the US Preventive Services Task Force Update on national hepatitis B guidelines. JAMA 324(23):2380-2382, 2020. PMID: 33320206.
Abstracts
- Torres HA, Mustafayev K, Juneau R, Hwang JP, Wang LS, Angelidakis G, Granwehr BP, Yepez Guevara E, Ying AK. Implementation of Universal Hepatitis C Virus Screening in a Tertiary Care Cancer Center. The Liver Meeting 2023, 2023.
Grant & Contract Support
| Title: | HBV reactivation among cancer patients receiving chemotherapy |
| Funding Source: | NIH/NCI K07 Career Development Award |
| Role: | Principal Investigator |
| Title: | Widespread vs. selective screening for hepatitis B infection prior to chemotherapy, CA167202-01A1 |
| Funding Source: | NIH/NCI R21 |
| Role: | Principal Investigator |
| Title: | Human Papillomavirus (HPV)-Associated Second Malignancies in Patients Who Receive Allogeneic Stem Cell Transplantation: Prospective Cohort |
| Funding Source: | Duncan Family Institute Seed Funding Research Program |
| Role: | Principal Investigator |
| Title: | Human Papillomavirus Antibody Response after GARDASIL® 9 Vaccination in Patients after Allogeneic Stem Cell Transplantation |
| Funding Source: | Merck & Co., Inc |
| Role: | Principal Investigator |
| Title: | SWOG S1614: A Phase III Randomized Trial of Prophylactic Antiviral Therapy in Patients with Current or Past Hepatitis B Virus (HBV) Infection Receiving Anti-cancer Therapy for Solid Tumors |
| Funding Source: | Gilead |
| Role: | Principal Investigator |
| Title: | Patient-centered Liver Cancer Prevention in the Houston Community |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Principal Investigator |
Patient Reviews
CV information above last modified October 04, 2024